Physician
Gonzalez, Christian
Gonzalez, Christian was paid $1.71M by Medicaid between Jan 2018 and Dec 2024, across 37 billing codes. Its largest line is 99233, hospital visit by a doctor, follow-up day (complex) — 45% of everything it billed.
33Billing provider infoGONZALEZ, CHRISTIAN
AVENTURA, FL 33180
AVENTURA, FL 33180
33aNPI1912987983assigned 01/18/2006
33bProvider typeAnesthesiology Physician
28Total paid$1.71M
24GClaims107,508
24DCodes billed37
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Anesthesiology Physician providers in Florida
Rank by total paid#7 of 148
Median peer was paid$20K
This provider vs. median86×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 11,989 | $102K | |
| 2019 | 22,941 | $430K | |
| 2020 | 21,266 | $467K | |
| 2021 | 24,975 | $522K | |
| 2022 | 11,786 | $135K | |
| 2023 | 10,849 | $54K | |
| 2024incomplete | 3,702 | $3K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99233 | Hospital visit by a doctor, follow-up day (complex)Prolong inpt eval add15 m | 45% | 32,704 | 8,694 | $762K |
| 99232 | Hospital visit by a doctor, follow-up daySubsequent hospital care, per day, moderate complexity | 13% | 14,598 | 3,712 | $221K |
| 99223 | Prolong inpt eval add15 m | 12% | 5,411 | 4,573 | $209K |
| 99255 | 8.2% | 1,532 | 1,200 | $140K | |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | 4.3% | 1,099 | 258 | $74K |
| 99231 | Subsequent hospital care, per day, straightforward or low complexity | 3.5% | 4,263 | 615 | $60K |
| 99222 | Initial hospital care, per day, moderate complexity | 2.6% | 1,821 | 1,632 | $44K |
| 99309 | Subsequent nursing facility care, per day, low to moderate complexity | 2.6% | 7,889 | 5,176 | $44K |
| 99254 | 2.3% | 382 | 316 | $39K | |
| 99308 | Subsequent nursing facility care, per day, straightforward | 2.2% | 12,419 | 7,507 | $38K |
| 99306 | Prolong nursin fac eval 15m | 1.6% | 3,091 | 2,623 | $27K |
| 99205 | Prolong outpt/office vis | <1% | 344 | 297 | $12K |
25 more codes
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 5,205 | $9K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 388 | $7K |
| 99305 | <1% | 1,302 | $6K | |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 7,208 | $6K |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 258 | $5K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 2,303 | $2K |
| 99335 | <1% | 389 | $2K | |
| L0650 | Lumbar-sacral orthosis, sagittal-coronal control, with rigid anterior and posterior frame/panel(s), posterior extends from sacrococcygeal junction to t-9 vertebra, lateral strength provided by rigid lateral frame/panel(s), produces intracavitary pressure to reduce load on intervertebral discs, includes straps, closures, may include padding, shoulder straps, pendulous abdomen design, prefabricated, off-the-shelf | <1% | 95 | $1K |
| 99334 | <1% | 205 | $738.11 | |
| 62323 | <1% | 220 | $634.93 | |
| L0637 | Lumbar-sacral orthosis, sagittal-coronal control, with rigid anterior and posterior frame/panels, posterior extends from sacrococcygeal junction to t-9 vertebra, lateral strength provided by rigid lateral frame/panels, produces intracavitary pressure to reduce load on intervertebral discs, includes straps, closures, may include padding, shoulder straps, pendulous abdomen design, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise | <1% | 23 | $549.58 |
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed | <1% | 673 | $322.83 |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 1,590 | $321.47 |
| 99336 | <1% | 340 | $171.54 | |
| 99307 | <1% | 159 | $114.98 | |
| 20610 | <1% | 27 | $44.07 | |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed | <1% | 232 | $1.98 |
| 99349 | 0% | 318 | $0.00 | |
| 80305 | 0% | 251 | $0.00 | |
| 77002 | 0% | 27 | $0.00 | |
| 99358 | Prolong nursin fac eval 15m | 0% | 82 | $0.00 |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed | 0% | 428 | $0.00 |
| 99348 | 0% | 172 | $0.00 | |
| 96138 | 0% | 34 | $0.00 | |
| G0452 | Molecular pathology procedure; physician interpretation and report | 0% | 26 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.